Skip to content

Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up

An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Equinoxe Proximal Humerus Fracture Plates Clinical and Radiographic Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05703958
Enrollment
151
Registered
2023-01-30
Start date
2023-04-19
Completion date
2034-09-30
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture Dislocation, Non-Union Fracture, Proximal Humeral Fracture

Brief summary

The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Proximal Humerus Fracture Plates over time. This study will follow subjects for a period of up to 10 years post-surgery.

Interventions

None listed

Sponsors

Exactech
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is indicated to receive Equinoxe Proximal Humerus Fracture Plate or has previously underwent primary surgery with Equioxe Proximal Humerus Fracture Plate * Patient is willing to participate by complying with pre- and postoperative visit requirements * Patient is willing to agree to be followed for up to 10 years following their index surgery * Patient is willing and able to review and sign a study informed consent form

Exclusion criteria

* Osteomyelitis of the proximal humerus or scapula * Inadequate or malformed bone that precludes adequate support or fixation of the prosthesis * Patient's age, weight, or activity level would cause the surgeon to expect early failure of the system * The patient is unwilling or unable to comply with the post-operative care instructions * Alcohol, drug, or other subtance abuse * Any disease state that could adversaly affect the function or longevity of the implant * Patient is pregnant * Patient is a prisoner * Patient has a physical or mental condition that would invalidate the results

Design outcomes

Primary

MeasureTime frameDescription
Smart ScoreThrough study completion, an average of 1 per yearShoulder Arthroplasty Smart (SAS) score - 6 questions based on 3 objective active range of motion and 3 subjective measures of pain and function. Score range of 0 to 100 where 100 indicates the best score
Sane ScoreThrough study completion, an average of 1 per yearSingle Assessment Numeric Evaluation (SANE) - Patient shoulder self-evaluation as a percentage of normal, 100% corresponds being normal
ASESThrough study completion, an average of 1 per yearAmerican Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition
Quick DASHThrough study completion, an average of 1 per yearShorten version of Disability of the Arm, Shoulder, and Hand (DASH) - 11 items to measure ability of a patient to perform certain upper extremity where 0 corresponds to no difficulty and 100 corresponds to unable

Countries

United States

Contacts

CONTACTRachael Craig
rachael.craig@advita.com1-833-423-8482
CONTACTSandrine Angibaud
sandrine.angibaud@advita.com1-833-423-8482
PRINCIPAL_INVESTIGATORAbhishek Ganta, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026